Basel, Switzerland
Did you know a single clinical trial can emit as much CO2 as 10+ households in a year? In biopharma industry, conducting clinical trials are necessary, but globally it also emit around 28 million tons of CO₂ equivalent annually, on par with the emissions of a small country.
As sustainability becomes a growing priority across the healthcare sector, clinical trials are increasingly coming under the spotlight. With their complex logistics, resource-heavy operations, and global footprints, trials present a real challenge when it comes to reducing environmental impact. So the big question is: how can we make clinical trials more sustainable—without compromising innovation or patient care?
In the Open Mic: Next in health series, our CEO, Dr. Linus Kao, will join three other industrial experts to explored how digital tools are driving change in this area:
🔹Daniel Guedelha, CEO & Founder, GenH
🔹Jürgen Wieland, Development Environmental Sustainability Lead, Novartis
🔹James Connelly, CEO, My Green Lab
🔹Linus Kao, Ph.D, CEO, Skyvor Medical
From decentralized trial designs and digital supply chain tracking to AI-powered digital solutions for improving operational efficiency, the panel shared valuable insights on cutting emissions, reducing waste, and making clinical trials more environmentally friendly.
The full event summary can be found in DayOne blog
How digital tools can maximize sustainability in clinical trials